Internet cognitive behavioral therapy for seniors with depression
The New Internet Generation: iCBT Treatment for Seniors With Mild-moderate Depression - a Pragmatic Randomised Controlled Trial in the Primary Care Context
This study is testing if an online therapy program can help seniors aged 65 and older with mild to moderate depression feel better compared to regular treatment they usually get.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 390 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Göteborg University Academic / other |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT06537869 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of internet cognitive behavioral therapy (iCBT) for elderly patients aged 65 and older with mild to moderate depression, comparing it to standard treatment as usual (TAU) in primary care settings. Participants will engage in a 10-12 week iCBT program with minimal therapist contact, while the control group will receive TAU according to Swedish National Guidelines. The study will assess various outcomes, including depressive symptoms, quality of life, and daily functioning, over a follow-up period of up to 36 months.
Who should consider this trial
Good fit: Ideal candidates are individuals over 65 years old with mild to moderate depressive symptoms attending primary care centers.
Not a fit: Patients with severe depression, a history of suicide attempts, or other significant psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide an accessible and effective treatment option for elderly patients suffering from depression.
How similar studies have performed: Previous studies have shown promising results for iCBT in younger populations, but this specific application for seniors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients \>65, attending PCCs engaged in the trial, with mood as well as somatic complaints will be asked about depressive symptoms during the last 2 weeks by NICE guidelines for depression. * All patients diagnosed with minor/major depression and not belonging to exclusion criteria and willing to take part in the trial will be diagnosed via the Mini International Neuropsychiatric Interview (M.I.N.I.) by a psychologist/specially trained nurse and have a General Practitioner (GP) somatic consultation Exclusion Criteria: Patients diagnosed with: * severe depression * prior suicide attempt or currently at medium to high risk of suicide (MADRS-S question 9\>3 points or MINI suicide \>9) * bipolar disorder * psychosis * addiction * cognitive impairment * not speaking or understanding Swedish.
Where this trial is running
Gothenburg
- University of Gothenburg — Gothenburg, Sweden (Recruiting)
Study contacts
- Principal investigator: Dominique Hange, Ass Prof — Göteborg University
- Study coordinator: Dominique Hange, Ass Prof
- Email: dominique.hange@allmed.gu.se
- Phone: +46722 245 700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.